Abstract:Myocardial infarction is the leading cause of death and disability worldwide, and the development of new treatments can help reduce the size of myocardial infarction and prevent adverse cardiovascular events. Cardiac repair after myocardial infarction can effectively remove necrotic tissue, induce neovascularization, and ultimately replace granulation tissue. Cardiac inflammation is the primary determinant of whether beneficial cardiac repair occurs after myocardial infarction. Immune cells mediate inflammatory responses and play a dual role in injury and protection during cardiac repair. After myocardial infarction, genetic ablation or blocking of anti-inflammatory pathways is often harmful. However, enhancing endogenous anti-inflammatory pathways or blocking endogenous pro-inflammatory pathways may improve cardiac repair after myocardial infarction. A deficiency of neutrophils or monocytes does not improve overall cardiac function after myocardial infarction but worsens it and aggravates cardiac fibrosis. Several factors are critical in regulating inflammatory genes and immune cells’ phenotypes, including DNA methylation, histone modifications, and non-coding RNAs. Therefore, strict control and timely suppression of the inflammatory response, finding a balance between inflammatory cells, preventing excessive tissue degradation, and avoiding infarct expansion can effectively reduce the occurrence of adverse cardiovascular events after myocardial infarction. This article reviews the involvement of neutrophils, monocytes, macrophages, and regulatory T cells in cardiac repair after myocardial infarction. After myocardial infarction, neutrophils are the first to be recruited to the damaged site to engulf necrotic cell debris and secrete chemokines that enhance monocyte recruitment. Monocytes then infiltrate the infarct site and differentiate into macrophages and they release proteases and cytokines that are harmful to surviving myocardial cells in the pre-infarct period. As time progresses, apoptotic neutrophils are cleared, the recruitment of anti-inflammatory monocyte subsets, the polarization of macrophages toward the repair phenotype, and infiltration of regulatory T cells, which secrete anti-inflammatory factors that stimulate angiogenesis and granulation tissue formation for cardiac repair. We also explored how epigenetic modifications regulate the phenotype of inflammatory genes and immune cells to promote cardiac repair after myocardial infarction. This paper also elucidates the roles of alarmin S100A8/A9, secreted frizzled-related protein 1, and podoplanin in the inflammatory response and cardiac repair after myocardial infarction.

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation

The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair

Macrophage-driven Cardiac Inflammation and Healing: Insights from Homeostasis and Myocardial Infarction

Insight into the Pro-inflammatory and Profibrotic Role of Macrophage in Heart Failure with Preserved Ejection Fraction.

Macrophages' Role in Tissue Disease and Regeneration

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Cardiac monocytes and macrophages after myocardial infarction

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Macrophages in Ischemic Heart Failure: Yesterday, Today, and Tomorrow

Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction

Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis

Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated

Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction

The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches

Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling